Remove 2020 Remove Clinical Pharmacology Remove Compounding
article thumbnail

Recommended Medical Reference

RX Note

Adverse Drug Reaction Drug Induced Diseases, 2018 Meyler's Side Effects of Drugs, 2015 Antibiotics The Sanford Guide to Antimicrobial Therapy, 2022 Breastfeeding Briggs' Drugs in Pregnancy and Lactation, 2021 Hale's Medications and Mothers' Milk, 2021 Clinical Practice Applied Therapeutics, 2018 Conn’s Current Therapy, 2022 Current Medical Diagnosis (..)

article thumbnail

FDA Advisory Committee Review of 2021

Eye on FDA

And speaking of divergent outcomes – one of the most notable occurrences in 2020 was the number of resignations that occurred in the wake of FDA’s decision to approve Aduhelm for Alzheimer’s Disease after an overwhelming committee vote recommending the agency decline to approve. Taking Care of AdComm Vacancies.

article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

Clinical trials Growing internal capabilities Approximately 90 percent of the investment required to develop new medicines is the cost of conducting clinical trials. Dr Mieke Borgs has been Head of Clinical Operations Europe at BeiGene since May 2020.